Supernus Pharmaceuticals (SUPN) Short Interest Ratio & Short Volume $35.23 -0.20 (-0.56%) (As of 10:44 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Supernus Pharmaceuticals Short Interest DataSupernus Pharmaceuticals (SUPN) has a short interest of 6.45 million shares, representing 12.20% of the float (the number of shares available for trading by the public). This marks a -1.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 17.8, indicating that it would take 17.8 days of the average trading volume of 437,172 shares to cover all short positions.Current Short Interest6,450,000 sharesPrevious Short Interest6,520,000 sharesChange Vs. Previous Month-1.07%Dollar Volume Sold Short$235.88 millionShort Interest Ratio17.8 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares55,219,000 sharesFloat Size52,880,000 sharesShort Percent of Float12.20%Today's Trading Volume35,200 sharesAverage Trading Volume437,172 sharesToday's Volume Vs. Average8% Short Selling Supernus Pharmaceuticals? Sign up to receive the latest short interest report for Supernus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSUPN Short Interest Over TimeSUPN Days to Cover Over TimeSUPN Percentage of Float Shorted Over Time Ad Wealthpin ProVacuum up cash with these special trades? Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. Supernus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20246,450,000 shares $235.88 million -1.1%12.2%17.8 $36.57 11/15/20246,520,000 shares $231.92 million -4.1%12.3%18.3 $35.57 10/31/20246,800,000 shares $231.68 million +0.4%12.9%18.1 $34.07 10/15/20246,770,000 shares $226.93 million -2.9%12.8%17.2 $33.52 9/30/20246,970,000 shares $217.32 million +2.5%13.2%15.8 $31.18 9/15/20246,800,000 shares $211.55 million +2.0%12.9%14.1 $31.11 Get the Latest News and Ratings for SUPN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Supernus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20246,670,000 shares $234.52 million +1.7%12.6%12.5 $35.16 8/15/20246,560,000 shares $224.68 million +6.5%12.4%11.4 $34.25 7/31/20246,160,000 shares $183.69 million -2.4%11.7%9.8 $29.82 7/15/20246,310,000 shares $181.29 million +3.1%12.0%10.9 $28.73 6/30/20246,120,000 shares $163.71 million +4.9%11.6%11 $26.75 6/15/20245,834,000 shares $151.63 million +11.8%11.1%11 $25.99 5/31/20245,220,000 shares $141.57 million +6.3%9.9%10.6 $27.12 5/15/20244,910,000 shares $141.11 million +1.9%9.3%10.2 $28.74 4/30/20244,820,000 shares $145.08 million +3.0%9.2%11.8 $30.10 4/15/20244,680,000 shares $140.35 million -2.9%8.9%12.1 $29.99 3/31/20244,820,000 shares $164.41 million -2.0%9.2%12.3 $34.11 3/15/20244,920,000 shares $162.26 million +11.6%9.4%13 $32.98 2/29/20244,410,000 shares $130.98 million +9.4%8.4%12.2 $29.70 2/15/20244,030,000 shares $115.50 million +7.8%7.7%12.1 $28.66 1/31/20243,740,000 shares $103.52 million -16.9%7.1%10.6 $27.68 1/15/20244,500,000 shares $127.08 million +0.2%8.6%11.8 $28.24 12/31/20234,490,000 shares $129.94 million +0.9%N/A0 $28.94 12/15/20234,450,000 shares $121.26 million +7.0%8.5%10.9 $27.25 11/30/20234,160,000 shares $113.36 million +0.2%7.9%9.5 $27.25 11/15/20234,150,000 shares $118.65 million +4.5%7.9%9.3 $28.59 10/31/20233,970,000 shares $94.68 million +1.8%7.6%8.6 $23.85 10/15/20233,900,000 shares $96.88 million -0.5%7.5%8.6 $24.84 9/30/20233,920,000 shares $108.07 million -9.1%7.5%9.1 $27.57 9/15/20234,310,000 shares $125.98 million +3.9%8.2%9.6 $29.23 8/31/20234,150,000 shares $132.14 million +1.0%7.9%8.9 $31.84 8/15/20234,110,000 shares $130.86 million -1.0%7.9%8.8 $31.84 7/31/20234,150,000 shares $127.36 million -25.0%8.0%8.7 $30.69 7/15/20235,530,000 shares $166.07 million -0.9%10.6%12.5 $30.03 6/30/20235,580,000 shares $167.73 million +2.2%10.7%12.4 $30.06 6/15/20235,460,000 shares $183.40 million +3.2%10.5%12.5 $33.59 5/31/20235,290,000 shares $175.31 million +10.9%10.1%13.3 $33.14 5/15/20234,770,000 shares $165.71 million +6.5%9.1%11.6 $34.74 4/30/20234,480,000 shares $165.13 million +10.6%8.6%11.2 $36.86 4/15/20234,050,000 shares $146.04 million +1.5%7.8%9.7 $36.06Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem 3/31/20233,990,000 shares $144.56 million -10.5%7.7%9.6 $36.23 3/15/20234,460,000 shares $158.37 million -3.5%8.6%10.4 $35.51 2/28/20234,620,000 shares $173.67 million -4.7%8.9%11.5 $37.59 2/15/20234,850,000 shares $187.02 million -9.4%9.4%12.7 $38.56 1/31/20235,350,000 shares $219.40 million -3.3%10.3%13.2 $41.01 1/15/20235,530,000 shares $220.54 million +0.6%10.7%15 $39.88 12/30/20225,500,000 shares $196.19 million +11.8%10.6%14.3 $35.67 12/15/20224,920,000 shares $174.56 million -13.4%9.5%12.6 $35.48 11/30/20225,680,000 shares $208.57 million -0.5%11.0%14.6 $36.72 11/15/20225,710,000 shares $194.14 million -3.4%11.0%14.6 $34.00 10/31/20225,910,000 shares $202.54 million -1.8%11.5%14.6 $34.27 10/15/20226,020,000 shares $195.41 million -1.3%11.7%14.5 $32.46 9/30/20226,100,000 shares $206.49 million -0.7%11.9%14.6 $33.85 9/15/20226,140,000 shares $213.86 million +8.1%12.0%16.1 $34.83 8/31/20225,680,000 shares $194.43 million +3.8%11.1%15.5 $34.23 8/15/20225,470,000 shares $185.93 million -2.0%10.7%15.6 $33.99 7/31/20225,580,000 shares $177.17 million -0.9%11.0%14.5 $31.75 7/15/20225,630,000 shares $167.10 million +0.9%11.1%15.1 $29.68 6/30/20225,580,000 shares $161.37 million +1.3%11.0%13.5 $28.92 6/15/20225,510,000 shares $151.14 million -2.5%10.9%13 $27.43 5/31/20225,650,000 shares $157.47 million +6.6%11.0%13.5 $27.87 5/15/20225,300,000 shares $141.99 million +2.7%10.3%10.8 $26.79 4/30/20225,160,000 shares $143.96 million +1.8%10.1%10.9 $27.90 4/15/20225,070,000 shares $157.68 million +6.7%9.9%10.8 $31.10 3/31/20224,750,000 shares $153.52 million -2.1%9.3%10.6 $32.32 3/15/20224,850,000 shares $146.37 million -12.5%9.5%11.4 $30.18 2/28/20225,540,000 shares $177.00 million -19.4%10.8%11.9 $31.95 2/15/20226,870,000 shares $209.88 million -3.8%13.4%15.6 $30.55 1/31/20227,140,000 shares $220.27 million -3.9%13.9%16.9 $30.85 1/15/20227,430,000 shares $225.57 million +2.1%14.5%17.7 $30.36 12/31/20217,280,000 shares $212.28 million -5.1%14.2%16.9 $29.16 12/15/20217,670,000 shares $219.67 million +6.5%15.0%17.5 $28.64 11/30/20217,200,000 shares $215.78 million +0.3%14.1%17.9 $29.97 11/15/20217,180,000 shares $234.00 million -7.4%14.0%17.9 $32.59 10/29/20217,750,000 shares $231.34 million +1.8%15.1%19.6 $29.85 10/15/20217,610,000 shares $240.93 million -0.9%14.9%19.7 $31.66 9/30/20217,680,000 shares $204.83 million +1.9%15.0%19.4 $26.67 9/15/20217,540,000 shares $203.66 million +2.0%14.7%17.8 $27.01 8/31/20217,390,000 shares $203.45 million -1.5%14.4%16.6 $27.53 8/13/20217,500,000 shares $185.55 million No Change14.7%17.3 $24.74 7/30/20217,500,000 shares $197.48 million -6.7%14.7%17.1 $26.33 7/15/20218,040,000 shares $212.34 million -12.0%15.7%17.7 $26.41 6/30/20219,140,000 shares $281.42 million +8.4%17.9%20 $30.79 6/15/20218,430,000 shares $269.09 million -6.2%16.5%16.8 $31.92 5/28/20218,990,000 shares $268.35 million +1.9%17.6%18.4 $29.85 5/14/20218,820,000 shares $263.10 million -1.2%17.3%15.1 $29.83 4/30/20218,930,000 shares $279.24 million +9.8%17.5%15.4 $31.27 4/15/20218,130,000 shares $259.10 million +10.8%15.9%13.9 $31.87 3/31/20217,340,000 shares $192.05 million -1.7%14.4%12.3 $26.17 3/15/20217,470,000 shares $199.45 million No Change14.6%11.5 $26.70Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem 2/26/20217,470,000 shares $219.99 million +4.5%14.7%11.6 $29.45 2/12/20217,150,000 shares $219.15 million +5.2%14.1%12.6 $30.65 1/29/20216,800,000 shares $205.09 million +5.3%13.5%10.9 $30.16 1/15/20216,460,000 shares $185.98 million +0.6%12.8%10 $28.79 12/31/20206,420,000 shares $161.01 million +8.5%12.7%10.8 $25.08 12/15/20205,920,000 shares $128.35 million +3.1%11.7%10.4 $21.68 11/30/20205,740,000 shares $125.53 million +1.6%11.4%12.1 $21.87 11/15/20205,650,000 shares $130.01 million +8.9%11.2%11.5 $23.01 10/30/20205,190,000 shares $95.24 million +1.4%10.3%10.6 $18.35 10/15/20205,120,000 shares $105.06 million -1.4%10.2%12.1 $20.52 9/30/20205,190,000 shares $108.16 million -2.3%10.3%11.4 $20.84 9/15/20205,310,000 shares $116.61 million -1.7%10.6%11.2 $21.96 8/31/20205,400,000 shares $118.75 million +0.4%10.7%11.4 $21.99 8/14/20205,380,000 shares $129.93 million +12.1%10.7%10.9 $24.15 7/31/20204,800,000 shares $106.85 million +5.5%9.5%9.8 $22.26 7/15/20204,550,000 shares $108.75 million +2.0%9.0%8.8 $23.90 6/30/20204,460,000 shares $103.78 million +4.5%8.8%8.2 $23.27 6/15/20204,270,000 shares $98.51 million +1.4%8.4%7.7 $23.07 5/29/20204,210,000 shares $101.55 million +3.2%8.3%6.8 $24.12 5/15/20204,080,000 shares $95.47 million +3.0%8.1%5.9 $23.40 4/30/20203,960,000 shares $92.66 million -10.6%7.8%5.8 $23.40 4/15/20204,430,000 shares $83.55 million -0.7%8.7%7 $18.86 3/31/20204,460,000 shares $84.52 million -20.1%8.8%7.2 $18.95 3/13/20205,581,700 shares $104.99 million -10.4%11.0%8.5 $18.81 2/28/20206,230,000 shares $102.86 million -2.8%12.3%10.4 $16.51 2/14/20206,410,000 shares $104.74 million -6.0%12.6%11 $16.34 1/31/20206,820,000 shares $133.13 million +4.3%13.5%11.7 $19.52 1/15/20206,540,000 shares $153.36 million +2.4%12.9%9.3 $23.45 12/31/20196,390,000 shares $150.61 million +7.9%12.6%9.1 $23.57 SUPN Short Interest - Frequently Asked Questions What is Supernus Pharmaceuticals' current short interest? Short interest is the volume of Supernus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 6,450,000 shares of SUPN short. 12.20% of Supernus Pharmaceuticals' shares are currently sold short. Learn More on Supernus Pharmaceuticals' current short interest. What is a good short interest ratio for Supernus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SUPN shares currently have a short interest ratio of 18.0. Learn More on Supernus Pharmaceuticals's short interest ratio. What is a good short interest percentage for Supernus Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.20% of Supernus Pharmaceuticals' floating shares are currently sold short. Is Supernus Pharmaceuticals' short interest increasing or decreasing? Supernus Pharmaceuticals saw a drop in short interest during the month of November. As of November 30th, there was short interest totaling 6,450,000 shares, a drop of 1.1% from the previous total of 6,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Supernus Pharmaceuticals' float size? Supernus Pharmaceuticals currently has issued a total of 55,219,000 shares. Some of Supernus Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Supernus Pharmaceuticals currently has a public float of 52,880,000 shares. How does Supernus Pharmaceuticals' short interest compare to its competitors? 12.20% of Supernus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Supernus Pharmaceuticals: Jazz Pharmaceuticals plc (7.34%), Corcept Therapeutics Incorporated (18.90%), Perrigo Company plc (2.95%), Pacira BioSciences, Inc. (10.40%), Omeros Co. (16.11%), Nektar Therapeutics (2.49%), Assembly Biosciences, Inc. (0.36%), Cumberland Pharmaceuticals Inc. (2.09%), Eli Lilly and Company (0.69%), Johnson & Johnson (0.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Supernus Pharmaceuticals stock? Short selling SUPN is an investing strategy that aims to generate trading profit from Supernus Pharmaceuticals as its price is falling. SUPN shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Supernus Pharmaceuticals? A short squeeze for Supernus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SUPN, which in turn drives the price of the stock up even further. How often is Supernus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SUPN, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies JAZZ Short Squeeze CORT Short Squeeze PRGO Short Squeeze PCRX Short Squeeze OMER Short Squeeze NKTR Short Squeeze ASMB Short Squeeze CPIX Short Squeeze LLY Short Squeeze JNJ Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SUPN) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredCackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America b...DTI | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMysterious drone activity triggers massive 1,366% surgeIf mysterious drones buzzing over the East Coast weren’t on your radar this year, you’re not alone. But her...Insiders Exposed | SponsoredIf you see ONE chart today… make it this one$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Go...ProsperityPub | Sponsored70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all po...WealthPress | SponsoredHow Low-Cost Stocks Generate Monthly IncomeAre you ready to transform your investment strategy and generate a steady monthly income? We’re excited to ...Darwin | SponsoredVacuum up cash with these special trades? Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formu...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SUPN Stock Alerts